<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
Epilepsy, a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, affects millions worldwide.<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
Overview of Cannabis and its Medicinal Components<\/p>\n\n\n\n
<\/p>\n\n\n\n
Cannabis is a plant used medicinally for thousands of years.<\/p>\n\n\n\n
The primary active compounds are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).<\/p>\n\n\n\n
THC is psychoactive, responsible for the ‘high’ associated with cannabis use, while CBD is not.<\/p>\n\n\n\n
These compounds interact with the body’s endocannabinoid system, involved in numerous physiological processes, including modulation of seizure activity, suggesting potential for cannabis in epilepsy management.<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
Epilepsy and Cannabis<\/p>\n\n\n\n
<\/p>\n\n\n\n
Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures.<\/p>\n\n\n\n
These seizures result from abnormal brain activity and can cause a variety of symptoms, from brief lapses in attention to convulsions.<\/p>\n\n\n\n
Epilepsy can be treated with anti-epileptic drugs, but these can have significant side effects and are not always effective.<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
Research on Cannabis for Epilepsy<\/p>\n\n\n\n
<\/p>\n\n\n\n
The therapeutic potential of cannabis, particularly CBD, for epilepsy has been investigated in recent years.<\/p>\n\n\n\n
A landmark study published in The New England Journal of Medicine in 2017 found that CBD significantly reduced the frequency of seizures in children with Dravet syndrome, a severe form of epilepsy (Devinsky et al., 2017).<\/p>\n\n\n\n
Other studies, including a 2018 double-blind randomized controlled trial published in The Lancet, found that CBD resulted in a greater reduction in seizure frequency for patients with Lennox-Gastaut syndrome, another severe form of epilepsy (Thiele et al., 2018).<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
Recommended Strains for Epilepsy<\/p>\n\n\n\n
<\/p>\n\n\n\n
Some cannabis strains may be more beneficial for epilepsy, particularly those high in Indica strains. It was noted that seizures significantly reduced after taking oil extracted from this strain in a young girl with Dravet syndrome characterised by many episodes of seizures.<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
Patient Stories<\/p>\n\n\n\n
<\/p>\n\n\n\n
There are numerous anecdotes of epilepsy patients experiencing fewer or less severe seizures with cannabis use.<\/p>\n\n\n\n
Many patients find they experience fewer side effects with cannabis than with traditional anti-epileptic drugs.<\/p>\n\n\n\n
<\/p>\n\n\n\n
Potential Side Effects and Risks<\/p>\n\n\n\n
<\/p>\n\n\n\n
Cannabis can cause side effects like dry mouth, fatigue, and dizziness.<\/p>\n\n\n\n
It can also impair short-term memory and coordination and increase heart rate.<\/p>\n\n\n\n
Long-term use can lead to cognitive impairment and mental health issues in susceptible individuals.<\/p>\n\n\n\n
<\/p>\n\n\n\n
Growing Cannabis for Medicinal Purposes<\/p>\n\n\n\n
<\/p>\n\n\n\n
If you’re considering growing your own cannabis for epilepsy management, several factors come into play.<\/p>\n\n\n\n
Choose strains that have demonstrated efficacy for seizure control.<\/p>\n\n\n\n
Understand your local legal regulations, provide adequate growing conditions, and prepare for challenges like pest control and nutrient management.<\/p>\n\n\n\n
<\/p>\n\n\n\n
Conclusion<\/p>\n\n\n\n
<\/p>\n\n\n\n
Medical cannabis, particularly CBD, shows promise in managing epilepsy, potentially offering relief for patients who have not responded to conventional treatments.<\/p>\n\n\n\n
While more research is needed, the existing evidence, along with patient experiences, offers hope.<\/p>\n\n\n\n
As always, remember the importance of discussing any new treatment with a healthcare professional.<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
References<\/p>\n\n\n\n
<\/p>\n\n\n\n
Devinsky, O., et al. (2017). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. New England Journal of Medicine, 376(21), 2011-2020.<\/p>\n\n\n\n
Thiele, E. A., et al. (2018). Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomized, double-blind, placebo-controlled phase 3 trial. The Lancet, 391(10125), 1085-1096.<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Epilepsy, a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, … <\/p>\n